Skip to main content
Premium Trial:

Request an Annual Quote

Harvard Bio Revenues Up 10 Percent, Profit Slips

NEW YORK (GenomeWeb News) - Harvard Bioscience yesterday said first-quarter revenue rose 10 percent as R&D spending increased 12 percent, and net income slipped 8 percent.
Total receipts for the three months ended March 31, 2007, increased to $19.1 million from $17.4 million year over year.
Harvard Bio said new sales stemming from the acquisition of Anthos' washer and microplate reader assets last June contributed 8 percent of revenue growth.
Fluctuations in foreign exchange rates contributed an additional 5 percent of revenue growth, but this was offset by a 3 percent decrease in organic revenue.  
R&D spending increased to $844,000 from $751,000 in the year-ago period. 
Harvard Bio reported net income of $496,000 in the quarter compared to $540,000 in the same period last year.
The company said it had around $8.6 million in cash and equivalents as of March 31.
Looking forward, Harvard Bioscience projected second-quarter revenue to be between $19.5 million and $20.5 million, and reaffirmed its expectation for revenue between $80 million and $83.0 million for full-year 2007.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.